Factors associated with risk analysis for asymptomatic left ventricular diastolic dysfunction in nondialysis patients with chronic kidney disease

References

• Matsushita K, Ballew SH, Wang AY, et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):1–12. doi: 10.1038/s41581-022-00616-6.
   PubMed Web of Science ®Google Scholar
• Taherkhani A, Farrokhi YR, Mohseni M, et al. Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers. Proteome Sci. 2019;17(1):7. doi: 10.1186/s12953-019-0155-y.
   PubMed Web of Science ®Google Scholar
• Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(12):1574–1585. doi: 10.1002/ejhf.813.
   PubMed Web of Science ®Google Scholar
• Redfield MM. Heart failure with preserved ejection fraction. N Engl J Med. 2016;375(19):1868–1877. doi: 10.1056/NEJMcp1511175.
   PubMed Web of Science ®Google Scholar
• Shiga T, Suzuki A, Haruta S, et al. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. 2019;6(3):475–486. doi: 10.1002/ehf2.12418.
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602. doi: 10.1038/nrcardio.2017.65.
   PubMed Web of Science ®Google Scholar
• Reddy YN, Borlaug BA. Heart failure with preserved ejection fraction. Curr Probl Cardiol. 2016;41(4):145–188. doi: 10.1016/j.cpcardiol.2015.12.002.
   PubMed Web of Science ®Google Scholar
• Yu AS, Pak KJ, Zhou H, et al. All-cause and cardiovascular-related mortality in CKD patients with and without heart failure: a population-based cohort study in Kaiser Permanente Southern California. Kidney Med. 2023;5(5):100624. doi: 10.1016/j.xkme.2023.100624.
   PubMedGoogle Scholar
• Tang M, Long Y, Liu S, et al. Prevalence of cardiovascular events and their risk factors in patients with chronic obstructive pulmonary disease and obstructive sleep apnea overlap syndrome. Front Cardiovasc Med. 2021;8:694806. doi: 10.3389/fcvm.2021.694806.
   PubMed Web of Science ®Google Scholar
• Pieske B, Tschöpe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020;22(3):391–412. doi: 10.1002/ejhf.1741.
   PubMed Web of Science ®Google Scholar
• Kitzman DW, Little WC, Brubaker PH, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 2002;288(17):2144–2150. doi: 10.1001/jama.288.17.2144.
   PubMed Web of Science ®Google Scholar
• Park M, Hsu CY, Li Y, et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012;23(10):1725–1734. doi: 10.1681/ASN.2012020145.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–e1032. doi: 10.1161/CIR.0000000000001063.
   PubMed Web of Science ®Google Scholar
• Kitai T, Miyakoshi C, Morimoto T, et al. Mode of death among Japanese adults with heart failure with preserved, midrange, and reduced ejection fraction. JAMA Netw Open. 2020;3(5):e204296. doi: 10.1001/jamanetworkopen.2020.4296.
   PubMed Web of Science ®Google Scholar
• Kapłon-Cieślicka A, Benson L, Chioncel O, et al. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC-HFA EORP Heart Failure Long-Term Registry. Eur J Heart Fail. 2022;24(2):335–350. doi: 10.1002/ejhf.2408.
   PubMed Web of Science ®Google Scholar
• Boxuan PU, Guangda HE, Runqing LI, et al. Differences and trends in health-related quality of life in hospitalized patients for heart failure with preserved, mildly reduced and reduced left ventricular ejection fraction. Chin Circ J. 2023;38(06):656–662.
   Google Scholar
• Bozkurt B, Coats AJ, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021. doi: 10.1016/j.cardfail.2021.01.022.
   Google Scholar
• Echouffo-Tcheugui JB, Erqou S, Butler J, et al. Assessing the risk of progression from asymptomatic left ventricular dysfunction to overt heart failure: a systematic overview and meta-analysis. JACC Heart Fail. 2016;4(4):237–248. doi: 10.1016/j.jchf.2015.09.015.
   PubMed Web of Science ®Google Scholar
• Zhang N, Feng B, Ma X, et al. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction. Cardiovasc Diabetol. 2019;18(1):107. doi: 10.1186/s12933-019-0914-1.
   PubMed Web of Science ®Google Scholar
• Kang E, Lee SW, Ryu H, et al. Left ventricular diastolic dysfunction and progression of chronic kidney disease: analysis of KNOW-CKD data. J Am Heart Assoc. 2022;11(13):e25554. doi: 10.1161/JAHA.122.025554.
   Web of Science ®Google Scholar
• Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi: 10.7326/0003-4819-158-11-201306040-00007.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, et al. Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int. 2007;72(12):1535–1542. doi: 10.1038/sj.ki.5002566.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–1360. doi: 10.1093/ehjci/jew082.
   PubMed Web of Science ®Google Scholar
• Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154–e235. doi: 10.1161/CIRCULATIONAHA.105.167586.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Bi Y, Wang L, Xu Y, et al. Diabetes-related metabolic risk factors in internal migrant workers in China: a national surveillance study. Lancet Diabetes Endocrinol. 2016;4(2):125–135. doi: 10.1016/S2213-8587(15)00366-6.
   PubMed Web of Science ®Google Scholar
• Vatcheva KP, Lee M, McCormick JB, et al. Multicollinearity in regression analyses conducted in epidemiologic studies. Epidemiology. 2016;6(2):227. doi: 10.4172/2161-1165.1000227.
   PubMedGoogle Scholar
• Stoltzfus JC. Logistic regression: a brief primer. Acad Emerg Med. 2011;18(10):1099–1104. doi: 10.1111/j.1553-2712.2011.01185.x.
   PubMed Web of Science ®Google Scholar
• Meurer WJ, Tolles J. Logistic regression diagnostics: understanding how well a model predicts outcomes. JAMA. 2017;317(10):1068–1069. doi: 10.1001/jama.2016.20441.
   PubMed Web of Science ®Google Scholar
• Bansal N, Roy J, Chen HY, et al. Evolution of echocardiographic measures of cardiac disease from CKD to ESRD and risk of all-cause mortality: findings from the CRIC study. Am J Kidney Dis. 2018;72(3):390–399. doi: 10.1053/j.ajkd.2018.02.363.
   PubMed Web of Science ®Google Scholar
• Liang HY, Hsiao YL, Yeh HC, et al. Associations between myocardial diastolic dysfunction and cardiovascular mortality in chronic kidney disease: a large single-center cohort study. J Am Soc Echocardiogr. 2022;35(4):395–407. doi: 10.1016/j.echo.2021.12.003.
   PubMed Web of Science ®Google Scholar
• Antlanger M, Aschauer S, Kopecky C, et al. Heart failure with preserved and reduced ejection fraction in hemodialysis patients: prevalence, disease prediction and prognosis. Kidney Blood Press Res. 2017;42(1):165–176. doi: 10.1159/000473868.
   PubMed Web of Science ®Google Scholar
• Winterberg PD, Robertson JM, Kelleman MS, et al. T cells play a causal role in diastolic dysfunction during uremic cardiomyopathy. J Am Soc Nephrol. 2019;30(3):407–420. doi: 10.1681/ASN.2017101138.
   PubMed Web of Science ®Google Scholar
• Li X, Zhu S, Song G, et al. Retinol-binding protein 4 is closely correlated to blood pressure level and E/A in untreated essential hypertension patients. Ann Palliat Med. 2019;8(5):645–650. doi: 10.21037/apm.2019.11.07.
   PubMed Web of Science ®Google Scholar
• Lawson CA, Tay WT, Bernhardt L, et al. Association between diabetes, chronic kidney disease, and outcomes in people with heart failure from Asia. JACC Asia. 2023;3(4):611–621. doi: 10.1016/j.jacasi.2023.03.005.
   PubMedGoogle Scholar
• Wang M, Li Y, Li S, et al. Endothelial dysfunction and diabetic cardiomyopathy. Front Endocrinol. 2022;13:851941. doi: 10.3389/fendo.2022.851941.
   PubMed Web of Science ®Google Scholar
• Jia G, Jia Y, Sowers JR. Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction. Biochim Biophys Acta Mol Basis Dis. 2017;1863(8):2012–2018. doi: 10.1016/j.bbadis.2016.10.025.
   PubMed Web of Science ®Google Scholar
• Lima-Posada I, Stephan Y, Soulié M, et al. Benefits of the non-steroidal mineralocorticoid receptor antagonist finerenone in metabolic syndrome-related heart failure with preserved ejection fraction. Int J Mol Sci. 2023;24(3):2536. doi: 10.3390/ijms24032536.
   PubMed Web of Science ®Google Scholar
• Ter Maaten JM, Damman K, Verhaar MC, et al. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail. 2016;18(6):588–598. doi: 10.1002/ejhf.497.
   PubMed Web of Science ®Google Scholar
• Nardi E, Mulè G, Nardi C, et al. Is echocardiography mandatory for patients with chronic kidney disease? Intern Emerg Med. 2019;14(6):923–929. doi: 10.1007/s11739-019-02028-0.
   PubMed Web of Science ®Google Scholar
• Gromadziński L, Januszko-Giergielewicz B, Pruszczyk P. Hypocalcemia is related to left ventricular diastolic dysfunction in patients with chronic kidney disease. J Cardiol. 2014;63(3):198–204. doi: 10.1016/j.jjcc.2013.08.003.
   PubMed Web of Science ®Google Scholar
• Ramadan SM, Hadeel AM, Nashwa A, et al. Left ventricular mass and functions in Egyptian children with chronic kidney disease in comparison to normal subjects. Saudi J Kidney Dis Transpl. 2022;33(2):296–306. doi: 10.4103/1319-2442.379028.
   PubMedGoogle Scholar
• Ayaz O, Banga S, Heinze-Milne S, et al. Long-term testosterone deficiency modifies myofilament and calcium-handling proteins and promotes diastolic dysfunction in the aging mouse heart. Am J Physiol Heart Circ Physiol. 2019;316(4):H768–H780. doi: 10.1152/ajpheart.00471.2018.
   PubMed Web of Science ®Google Scholar
• Pabel S, Wagner S, Bollenberg H, et al. Empagliflozin directly improves diastolic function in human heart failure. Eur J Heart Fail. 2018;20(12):1690–1700. doi: 10.1002/ejhf.1328.
   PubMed Web of Science ®Google Scholar
• Bers DM. Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction. Annu Rev Physiol. 2014;76(1):107–127. doi: 10.1146/annurev-physiol-020911-153308.
   PubMedGoogle Scholar
• Zhang L, Nan C, Chen Y, et al. Calcium desensitizer catechin reverses diastolic dysfunction in mice with restrictive cardiomyopathy. Arch Biochem Biophys. 2015;573:69–76. doi: 10.1016/j.abb.2015.03.015.
   PubMed Web of Science ®Google Scholar
• Mcdonald KS, Emter CA. Exploring new concepts in the management of heart failure with preserved ejection fraction: is exercise the key for improving treatment? J Appl Physiol (1985). 2015;119(6):724–725. doi: 10.1152/japplphysiol.00570.2015.
   PubMed Web of Science ®Google Scholar